.
MergerLinks Header Logo

New Deal


Announced

Completed

Goldman Sachs Asset Management led a $90m series A funding round in Nested Therapeutics.

Synopsis

Goldman Sachs Asset Management, an asset manager, led a $90m series A funding round in Nested Therapeutics, a biotech company. "Our drug discovery platform enables us to find new, overlooked areas of opportunity in the form of high confidence targets with unconventional pockets, while also generating the insights necessary to design therapeutics with novel mechanisms for a perfect fit. Patients deserve more and better options, and our approach holds the promise to make first- and best-in-class precision oncology treatments available to a larger addressable population," Darrin Miles, Nested Therapeutics CEO.

Show Details & Financials

Market Context

Search a database of more than 250,000 verified dealmakers

Receive automated updates on global transactions

Follow the activity, relationships and transactions of top dealmakers

No credit card required

© COPYRIGHT 2024 MERGERLINKS LIMITED.

ALL RIGHTS RESERVED.

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.

CONTACT US